SCHEMBL6844356

SCHEMBL6844356

CNCCCCCN1CN(c2ccccc2)C(c2ccccc2)=C1c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.37
SLC6A2 P23975 5/20 0.36
SLC6A4 P31645 2/20 0.36
HTR2A P28223 4/20 0.35
DRD2 P14416 3/20 0.35
CYP3A4 P08684 2/20 0.35
HRH1 P35367 2/20 0.35
HTT P42858 2/20 0.35
KCNH2 Q12809 2/20 0.35
SLC22A2 O15244 1/20 0.35
SLC22A1 O15245 1/20 0.35
SLC22A3 O75751 1/20 0.35
CYP1A2 P05177 1/20 0.35
CHRM2 P08172 1/20 0.35
CYP2D6 P10635 1/20 0.35
CHRM1 P11229 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6844344 0.99 L3MBTL1 (0.38) SIGMAR1L3MBTL1SLC6A2SLC6A4HTR2A
SCHEMBL6839538 0.94 SLC6A2 (0.40) SIGMAR1L3MBTL1SLC6A2SLC6A4HTR2A
SCHEMBL6844083 0.87 MAPT (0.34) HTR2ADRD2HTTKCNH2OPRK1
SCHEMBL6844072 0.85 MAPT (0.35) SIGMAR1HTR2ADRD2HTTDRD3
SCHEMBL6844078 0.85 SIGMAR1 (0.42) SIGMAR1L3MBTL1SLC6A2SLC6A4HTR2A
SCHEMBL6844337 0.83 L3MBTL1 (0.41) SIGMAR1L3MBTL1SLC6A2SLC6A4HTR2A
SCHEMBL6839506 0.81 MAPT (0.35) SLC6A2SLC6A4HTTOPRK1PRMT6
SCHEMBL6847081 0.71 HTT (0.36) SIGMAR1DRD2HTTCYP1A2CHRM2
SCHEMBL6844322 0.71 HTT (0.36) SIGMAR1DRD2HTTCYP1A2CHRM2
SCHEMBL1005114 0.70 NPC1 (0.44) SIGMAR1L3MBTL1CYP3A4MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents L'OREAL (FR) 2004-08-19 US claimed
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents L'OREAL (FR) 2004-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162328-A1 Compounds of the family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents TRPV1, TRPA1, TRPV3 SIGMAR1 1443/4885L3MBTL1 4171/4885SLC6A2 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.